CMS To Cut Medicare Part B 2023 Premiums After Lower Aduhelm Costs

HHS plans to lower Medicare Part B premiums in 2023 to compensate for this year’s lower-than-expected spending after CMS reports it overestimated the costs and patient use of the Alzheimer’s drug Aduhelm when calculating this year’s monthly premiums, which went up $21.60 for 2022 in part to pay for the controversial drug. But because of the difficulties with changing premiums mid-year, HHS has opted to lower the 2023 premiums for beneficiaries to make up for the overly high costs in...